India

DengiAll: ICMR & Panacea Biotec Initiate First Indigenous Dengue Vaccine Phase 3 Clinical Trial

By
OB Bureau

New Delhi: The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue vaccine in India. This landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec. The first participant in this trial was vaccinated at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, according to a PIB release.

Commenting on this milestone, Union Minister of Health & Family Welfare, Shri J.P. Nadda, said, “The initiation of this Phase 3 clinical trial for India’s first indigenous dengue vaccine marks a critical advancement in our fight against dengue. It reflects our commitment to protecting our citizens from this pervasive disease and underscores India’s capabilities in vaccine research and development. Through this collaboration between ICMR and Panacea Biotec, we are not only taking a step towards ensuring the health and well-being of our people but also reinforcing our vision of Atmanirbhar Bharat in the healthcare sector.”

Currently, there is no antiviral treatment or licensed vaccine against dengue in India. The development of an effective vaccine is complex due to the need to achieve good efficacy for all four serotypes. All four serotypes of Dengue virus are known to circulate or co-circulate in many regions in India.

The tetravalent dengue vaccine strain (TV003/TV005), originally developed by the National Institutes of Health (NIH), USA, has shown promising results in preclinical and clinical trials worldwide. Panacea Biotec, one of three Indian companies to receive the strain, is at the most advanced stage of development. The company has worked extensively on these strains to develop a full-fledged vaccine formulation and holds a process patent for this work. Phase 1 and 2 clinical trials of the Indian vaccine formulation were completed in 2018-19, yielding promising results.

In collaboration with ICMR, Panacea Biotec will conduct the Phase 3 clinical trial across 19 sites in 18 states and Union Territories of India, involving more than 10,335 healthy adult participants. The trial, primarily funded by ICMR with partial support from Panacea Biotec, is set to follow up with participants for two years. This initiative represents a significant step towards developing an indigenous vaccine for one of India’s most pressing public health challenges and exemplifies the nation’s commitment to Atmanirbhar Bharat.

 

OB Bureau

Recent Posts

Vishal Aditya Singh Calls Shweta Tiwari ‘Mom’, Breaks Silence On Fake Wedding Pictures

Mumbai: Recently, some morphed pictures of actress Shweta Tiwari and her good friend Vishal Aditya…

November 22, 2024

2 Tribal Men Get Life Imprisonment For Gangraping Minor Girl In Odisha

Phulbani: Two tribal men were sentenced to life imprisonment by a special court in Odisha's…

November 22, 2024

Atishi Or Kejriwal, Who Is The Better CM? Delhi’s Lt Gov Takes His Pick

New Delhi: It’s been just over two months since Atishi took oath as Delhi’s chief…

November 22, 2024

Dr Manita Tamang Of AIIMS Bhubaneswar Receives UC Chakroborty Award

Bhubaneswar: In a moment of pride for AIIMS Bhubaneswar, Dr Manita Tamang, a final-year Senior…

November 22, 2024

Amid Fresh Violence, 10,000 Additional Soldiers To Be Sent To Manipur

Imphal: In view of the surge in violence in troubled Manipur, the Central government will send…

November 22, 2024

Odisha Parba Kicks Off In Delhi In Presence Of President Murmu, Dharmendra Pradhan & CM Mohan Majhi

New Delhi/Bhubaneswar: The 7th edition of Odisha Parba got off to a colourful start in…

November 22, 2024

Nagarjuna Played Cupid In Naga Chaitanya, Sobhita Dhulipala’s Love Story; Know How

Mumbai: Celebrity couple Naga Chaitanya and Sobhita Dhulipala are set to walk down the aisle…

November 22, 2024

Coldplay Infinity Tickets Sold Out Within Seconds; Netizens Call It A ‘Scam’, Demand ‘Impartial Probe’

Mumbai: Ticket sales for the highly-anticipated Coldplay Infinity concerts across Indian cities kickstarted at 12…

November 22, 2024